Stock screenerAll disclosures →
EDGAR →
ACAD
Conviction 59HealthcareScan · Thu, Jun 25, 2026ACAD$23.73+1.58%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.54M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price23.73
Change+1.58%
Gap+0.00%
Rel volume3.03×
Avg volume1.46M
Avg $ vol32.05M
SMA 2021.74
SMA 5021.78
SMA 20023.24
Price vs 50+8.95%
Price vs 200+2.10%
MA stackmixed
50/200 cross—
Supertrendup · 21.54
RSI (14)69
MACD hist0.27
MACD crossbull · 5d
Stoch %K / %D89 / 90
ADX (14)22
+DI / −DI30 / 13
RSI divergence—
MACD divergence—
ATR %+3.00%
ADR %3.05%
52w high28.06
52w low20.06
From 52w high-15.43%
Above 52w low+18.30%
New 52w highNo
SqueezeOff
Bollinger width13.05%
%B1.20
Donchian pos88.96%
Donchian high24.10
Donchian low20.75
AVWAP (52w high)22.89
vs AVWAP high+3.69%
AVWAP (52w low)23.13
vs AVWAP low+2.60%
OBV trendUp
Chaikin MF (20)0.11
Today vs 20d3.03×
Avg vol (14d)1.54M
Avg vol (20d)1.46M
Avg $ vol (20d)32.05M
Market cap4.06B
RS 3m (vs SPY)-0.81%
RS 6m (vs SPY)-21.73%
RS line new highNo
Trend template4/8
Technical rank56.8
1 week+9.86%
1 month+11.62%
3 months+7.81%
6 months-15.43%
1 year+5.89%
YTD-9.74%
P/E10.39
P/B3.26
P/S3.79
P/FCF38.65
EPS2.30
Div yield—
ROE31.33%
ROA24.36%
Debt/Eq0.00
Current3.59
EV/EBITDA36.01
Gross margin63.91%
Net margin36.49%
Rev growth11.87%
EPS growth72.66%
Price target32.18
Target upside35.61%
Analyst ratingBuy
Institutional106.49%
Ent. value3.78B
Revenue268.06M
Net income3.64M
Gross profit—
Free cash flow105.15M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out171.24M
Employees798
ListedThu, May 27, 2004
Free float126.37M
Float %74.1%
Short interest11.75M
Days to cover8.1d
Short volume40.3%
Squeeze score59 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast$0.06 · 7 est
Last EPS vs est$0.02 vs $0.04
Last surprise-50.0% miss
Setup gradeC
Conviction59 / 100
Pattern quality—
Tech rank56.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance22.73
Support20.53
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ACAD
No recent disclosed trades by Congress in ACAD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ACAD · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BAKER JULIAN Director · Common Stock · 2026-05-29 | Grant | 18.62K | $0 | 2026-05-29 | 2026-06-02 |
Baker Bros. Advisors (GP) LLC Director · Non- Qualified Stock Option (right to buy) · 2026-05-29 | Grant | 32.01K | $0 | 2026-05-29 | 2026-06-02 |
Baker Bros. Advisors (GP) LLC Director · Common Stock · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-02 |
BAKER BROS. ADVISORS LP Director · Non- Qualified Stock Option (right to buy) · 2026-05-29 | Grant | 32.01K | $0 | 2026-05-29 | 2026-06-02 |
667, L.P. Director · Common Stock · 2026-05-29 | Grant | 18.62K | $0 | 2026-05-29 | 2026-06-02 |
667, L.P. Director · Non- Qualified Stock Option (right to buy) · 2026-05-29 | Grant | 32.01K | $0 | 2026-05-29 | 2026-06-02 |
BAKER BROS. ADVISORS LP Director · Common Stock · 2026-05-29 | Grant | 18.62K | $0 | 2026-05-29 | 2026-06-02 |
Baker Bros. Advisors (GP) LLC Director · Common Stock · 2026-05-29 | Grant | 18.62K | $0 | 2026-05-29 | 2026-06-02 |
BAKER FELIX Director · Common Stock · 2026-05-29 | Grant | 18.62K | $0 | 2026-05-29 | 2026-06-02 |
BAKER FELIX Director · Non- Qualified Stock Option (right to buy) · 2026-05-29 | Grant | 32.01K | $0 | 2026-05-29 | 2026-06-02 |
SEC filings
EDGAR filings in ACAD
No recent SEC filings on file for ACAD.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.